http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-845815-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c72d118f5664072de841f9c5c34b9d99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01B3-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01G4-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01G4-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01B3-46
filingDate 1958-07-24^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1960-08-24^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-845815-A
titleOfInvention Method for preparing chlorophenylchlorosilanes
abstract Chlorophenylchlorosilanes containing more than 3 nuclearly attached chlorine atoms per phenyl nucleus are prepared by chlorinating with gaseous chlorine a phenylchlorosilane of the formula (C6H5)n Si Cl4-n, where n is 1, 2 or 3, in the presence of a mixed catalyst system composed of ferric chloride and antimony pentachloride. Both catalyst compounds may be formed in situ during the chlorination from iron or an iron compound and from antimony or an antimony compound. Such compounds include ferrous chloride, ferric and ferrous acetates, iron hydroxide, ferric oxychloride and ferric octoate, and antimony trichloride, oxychloride, oxide, acetate and octoate. Preferably from 0,05 to 10 parts of ferric chloride are used per part of antimony chloride, and from 0.05 to 5% of the mixture based on the silane. Temperatures of about 75 DEG to 115 DEG C. are generally employed. The chlorophenylchlorosilanes are isolated by fractional distillation. The examples describe the chlorination of phenyltrichlorosilane, producing mixtures of tetrachlorophenyl trichlorosilane with small amounts of the di- and tri-chlorophenyl derivatives and chlorobenzenes, and of diphenyl dichlorosilane, producing mixtures of octachlorodiphenyl dichlorosilane with other chloror derivatives.ALSO:A mixture of ferric chloride and antimony pentachloride is used as catalyst in the chlorination of phenyl chlorosilanes (see Group IV(a)). Both compounds may be formed in situ during the chlorination from their metals or from other iron and antimony compounds. Such compounds include ferrous chloride, ferric and ferrous acetates, iron hydroxide, ferric oxychloride and ferric octoate, and antimony trichloride, oxychloride, oxide, acetate and octoate. Preferably from 0.05 to 10 parts of ferric chloride are used per part of antimony chloride. In examples the catalyst is formed by in situ reaction with chlorine of a mixture of Fe powder and SbCK. Specifications 544,143 and 673,322 are referred to.
priorityDate 1957-08-19^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451572259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414805607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458434260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20064706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451095370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415752960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450399660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415763944

Showing number of triples: 1 to 55 of 55.